Follow
fabienne ory magne
fabienne ory magne
Hospital practitioner of neurology, CHU Purpan, ToNIC (Inserm-UT3), TMBI (Univ. Toulouse)
Verified email at chu-toulouse.fr
Title
Cited by
Cited by
Year
Neurostimulation for Parkinson's disease with early motor complications
WMM Schuepbach, J Rau, K Knudsen, J Volkmann, P Krack, ...
New England Journal of Medicine 368 (7), 610-622, 2013
14692013
Levodopa raises objective pain threshold in Parkinson’s disease: a RIII reflex study
A Gerdelat-Mas, M Simonetta-Moreau, C Thalamas, F Ory-Magne, ...
Journal of Neurology, Neurosurgery & Psychiatry 78 (10), 1140-1142, 2007
2622007
Longitudinal analysis of impulse control disorders in Parkinson disease
JC Corvol, F Artaud, F Cormier-Dequaire, O Rascol, F Durif, ...
Neurology 91 (3), e189-e201, 2018
2252018
Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo …
C Moreau, A Delval, L Defebvre, K Dujardin, A Duhamel, G Petyt, ...
The lancet neurology 11 (7), 589-596, 2012
2142012
Levodopa-carbidopa intestinal gel in advanced Parkinson's: final results of the GLORIA registry
A Antonini, W Poewe, KR Chaudhuri, R Jech, B Pickut, Z Pirtošek, J Szasz, ...
Parkinsonism & related disorders 45, 13-20, 2017
1882017
Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial
F Ory-Magne, JC Corvol, JP Azulay, AM Bonnet, C Brefel-Courbon, ...
Neurology 82 (4), 300-307, 2014
1582014
Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts
G Liu, JJ Locascio, JC Corvol, B Boot, Z Liao, K Page, D Franco, K Burke, ...
The Lancet Neurology 16 (8), 620-629, 2017
1472017
Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial …
E Lhommée, L Wojtecki, V Czernecki, K Witt, F Maier, L Tonder, ...
The Lancet Neurology 17 (3), 223-231, 2018
1382018
Does ageing influence deep brain stimulation outcomes in Parkinson's disease?
F Ory‐Magne, C Brefel‐Courbon, M Simonetta‐Moreau, N Fabre, ...
Movement disorders: official journal of the Movement Disorder Society 22 (10 …, 2007
1262007
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial
GU Höglinger, I Litvan, N Mendonca, D Wang, H Zheng, ...
The Lancet Neurology 20 (3), 182-192, 2021
1022021
Apomorphine effect on pain threshold in Parkinson's disease: a clinical and positron emission tomography study
E Dellapina, A Gerdelat‐Mas, F Ory‐Magne, L Pourcel, M Galitzky, ...
Movement Disorders 26 (1), 153-157, 2011
1022011
International validation of a behavioral scale in Parkinson's disease without dementia
I Rieu, P Martinez‐Martin, B Pereira, I De Chazeron, L Verhagen Metman, ...
Movement Disorders 30 (5), 705-713, 2015
932015
Quality of life predicts outcome of deep brain stimulation in early Parkinson disease
WMM Schuepbach, L Tonder, A Schnitzler, P Krack, J Rau, A Hartmann, ...
Neurology 92 (10), e1109-e1120, 2019
912019
Nociceptive brain activation in patients with neuropathic pain related to Parkinson's disease
C Brefel-Courbon, F Ory-Magne, C Thalamas, P Payoux, O Rascol
Parkinsonism & Related Disorders 19 (5), 548-552, 2013
882013
Long-term efficacy and tolerability of bilateral pallidal stimulation to treat tardive dyskinesia
H Pouclet-Courtemanche, T Rouaud, S Thobois, JM Nguyen, ...
Neurology 86 (7), 651-659, 2016
862016
Exchangeable copper: a reflection of the neurological severity in W ilson's disease
A Poujois, JM Trocello, N Djebrani‐Oussedik, J Poupon, C Collet, ...
European Journal of Neurology 24 (1), 154-160, 2017
852017
Effect of subthalamic deep brain stimulation on pain in Parkinson’s disease
E Dellapina, F Ory-Magne, W Regragui, C Thalamas, Y Lazorthes, ...
PAIN® 153 (11), 2267-2273, 2012
812012
Trial of deferiprone in Parkinson’s disease
D Devos, J Labreuche, O Rascol, JC Corvol, A Duhamel, ...
New England Journal of Medicine 387 (22), 2045-2055, 2022
682022
Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson’s disease
C Moreau, S Meguig, JC Corvol, J Labreuche, F Vasseur, A Duhamel, ...
Brain 138 (5), 1271-1283, 2015
662015
Deep brain stimulation of the subthalamic nucleus improves pain in Parkinson's disease
J Pellaprat, F Ory-Magne, C Canivet, M Simonetta-Moreau, JA Lotterie, ...
Parkinsonism & related disorders 20 (6), 662-664, 2014
602014
The system can't perform the operation now. Try again later.
Articles 1–20